Dan Li
Direttore/Membro del Consiglio presso ZHONGCHAO INC.
Patrimonio netto: 2 682 $ in data 30/04/2024
Posizioni attive di Dan Li
Società | Posizione | Inizio | Fine |
---|---|---|---|
ZHONGCHAO INC. | Direttore/Membro del Consiglio | 06/08/2019 | - |
Independent Dir/Board Member | 06/08/2019 | - |
Storia della carriera di Dan Li
Precedenti posizioni note di Dan Li
Società | Posizione | Inizio | Fine |
---|---|---|---|
EPS HOLDINGS, INC. | Corporate Officer/Principal | 01/10/2009 | 01/11/2011 |
Formazione di Dan Li
North China University of Science & Technology | Undergraduate Degree |
Peking University | Graduate Degree |
Keio University | Doctorate Degree |
Statistiche
Distribuzione geografica
Cina | 4 |
Giappone | 3 |
Posizioni
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 4 |
Commercial Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ZHONGCHAO INC. | Commercial Services |
Aziende private | 1 |
---|---|
EPS Holdings, Inc.
EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Dan Li
- Esperienza